Invention Grant
US07750026B2 Fused heteroaryl derivatives and their use as p38 kinase inhibitors
失效
稠合的杂芳基衍生物及其作为p38激酶抑制剂的用途
- Patent Title: Fused heteroaryl derivatives and their use as p38 kinase inhibitors
- Patent Title (中): 稠合的杂芳基衍生物及其作为p38激酶抑制剂的用途
-
Application No.: US10587613Application Date: 2005-01-27
-
Publication No.: US07750026B2Publication Date: 2010-07-06
- Inventor: Vipulkumar Kantibhai Patel , Stephen Swanson
- Applicant: Vipulkumar Kantibhai Patel , Stephen Swanson
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent Dara L. Dinner; Theodore R. Furman
- Priority: GB0402138.2 20040130
- International Application: PCT/GB2005/000266 WO 20050127
- International Announcement: WO2005/073217 WO 20050811
- Main IPC: A61K31/423
- IPC: A61K31/423 ; A61K31/416 ; A61K31/4439 ; C07D413/02 ; C07D413/04 ; C07D403/02
Abstract:
Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
Public/Granted literature
- US20070054942A1 Fused heteroaryl derivatives and their use as p38 kinase inhibitors Public/Granted day:2007-03-08
Information query
IPC分类:
